Globus Medical launched the MARVEL Growing Rod System, which is designed for pediatric patients with early onset scoliosis to obtain and maintain correction while allowing for growth through minimally invasive distraction.
MARVEL growing rods feature a geared mechanism that provides efficient lengthening through a large 40mm or 60mm expansion range, with PEEK polymer bearing surfaces to minimize wear. Lengthening of each rod is achieved through a minimally invasive procedure with a small incision for driver access to minimize soft tissue disruption.
David Hole, President, Spine at Globus Medical, said, “MARVEL, together with our recent launch of the REFLECT Scoliosis Correction System, a non-fusion growth modulation system for treatment of skeletally immature idiopathic scoliosis patients, demonstrates our commitment to leveraging our product development engine to serve children with scoliosis and the surgeons who care for them. We are very excited to bring these innovations to the marketplace.”
Globus Medical launched the MARVEL Growing Rod System, which is designed for pediatric patients with early onset scoliosis to obtain and maintain correction while allowing for growth through minimally invasive distraction.
MARVEL growing rods feature a geared mechanism that provides efficient lengthening through a large 40mm or 60mm expansion...
Globus Medical launched the MARVEL Growing Rod System, which is designed for pediatric patients with early onset scoliosis to obtain and maintain correction while allowing for growth through minimally invasive distraction.
MARVEL growing rods feature a geared mechanism that provides efficient lengthening through a large 40mm or 60mm expansion range, with PEEK polymer bearing surfaces to minimize wear. Lengthening of each rod is achieved through a minimally invasive procedure with a small incision for driver access to minimize soft tissue disruption.
David Hole, President, Spine at Globus Medical, said, “MARVEL, together with our recent launch of the REFLECT Scoliosis Correction System, a non-fusion growth modulation system for treatment of skeletally immature idiopathic scoliosis patients, demonstrates our commitment to leveraging our product development engine to serve children with scoliosis and the surgeons who care for them. We are very excited to bring these innovations to the marketplace.”
Copy to clipboard 
